This article is authored by Dr Shoruba Dinakaran, consultant, cataract & glaucoma services, Happiest Netralaya, Happiest ...

A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...

PHOENIX — Historically, optic nerve involvement has been excluded from multiple sclerosis (MS) diagnostic criteria, but its inclusion in the upcoming 2024 McDonald Diagnostic Criteria is expected to ...

Immune checkpoint inhibitors (ICIs) have revolutionised the management of advanced malignancies, but can cause immune-related adverse events (irAEs), including vision-threatening complications such as ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the ...

When a childhood brain tumor threatens the very wiring of sight, doctors have few options that actually protect vision. Now, a four-year follow-up study of children with optic pathway gliomas who once ...

NYU Doctor: 'No Treatment' for Rare Eye Condition Tied to GLP-1 Drugs ...

The image show two optic nerves, six weeks after they have been crushed (injury marked with a rhombus.) The nerves project fibers from left to right. Live nerve tissue glows green in this image, while ...

Patients allege drugs including Wegovy and Mounjaro caused NAION, a rare form of optic nerve damage-and that they weren't warned of the potential risk.

The management of traumatic optic neuropathy has evolved to include surgical decompression aimed at relieving pressure within the optic canal. Direct injuries result from penetrating fragments, ...

Patients who were prescribed Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), or other GLP-1 receptor agonist medications to treat type 2 diabetes or for weight loss may be at risk ...